Latest News and Press Releases

PharmAla adds Matthew Azrieli to Advisory Team

PharmAla releases its Q1 financial statements

PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire

PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement

PharmAla announces private placement financing

PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.

PharmAla to supply Yale University with MDMA for clinical trial

PharmAla contracted to sell MDMA to Mt. Sinai Hospital, NY. Terminates Contract with CCrest Labs.

PharmAla signs contract to develop novel dosage form of LaNeo MDMA, to be used in clinical trial at University of Texas San Antonio

PharmAla Biotech signs contract to supply Harvard neuropsychiatry hospital with MDMA; Appears at CPHI Conference in Milan